Repurposing the anti-epileptic drug sodium valproate as an adjuvant treatment for diffuse intrinsic pontine glioma.
Targeting epigenetic changes in diffuse intrinsic pontine glioma (DIPG) may provide a novel treatment option for patients. This report demonstrates that sodium valproate, a histone deacetylase inhibitor (HDACi), can increase the cytotoxicity of carboplatin in an additive and synergistic manner in DI...
Main Authors: | Clare L Killick-Cole, William G B Singleton, Alison S Bienemann, Daniel J Asby, Marcella J Wyatt, Lisa J Boulter, Neil U Barua, Steven S Gill |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5444593?pdf=render |
Similar Items
-
Combined use of CDK4/6 and mTOR inhibitors induce synergistic growth arrest of diffuse intrinsic pontine glioma cells via mutual downregulation of mTORC1 activity
by: Asby DJ, et al.
Published: (2018-09-01) -
Pediatric diffuse intrinsic pontine gliomas
by: Huber Said Padilla-Zambrano, et al.
Published: (2019-01-01) -
Convection enhanced delivery of panobinostat (LBH589)-loaded pluronic nano-micelles prolongs survival in the F98 rat glioma model
by: Singleton WG, et al.
Published: (2017-02-01) -
Pre-Clinical Models of Diffuse Intrinsic Pontine Glioma
by: Oren J Becher, et al.
Published: (2015-07-01) -
The neurovascular unit in diffuse intrinsic pontine gliomas
by: Fatma E. El-Khouly, et al.
Published: (2021-07-01)